
Susa Ventures is an early-stage venture capital firm that invests in "spiky founders" building category-defining companies with "compounding moats" through defensible products, technologies, and proprietary data. Their investment focus primarily spans AI-driven companies, fintech, digital health, logistics, and supply chain.
Deal activity increased 250% year-over-year (7 deals in the last 12 months). Average disclosed round size is $44.9M (across 56 rounds with reported amounts).
Portfolio
58
Fund Size
$175M
Top Stage
Seed
Last 12 Mo
7
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
DealsAvg Round Size
Portfolio
58 investments
| Company | Round | Amount | Date |
|---|---|---|---|
| AAsymmetric Security | Pre-Seed | $4.2M | Jan 2026 |
| Seed | $9M | Dec 2025 | |
| Pre-Seed | $2.6M | Oct 2025 | |
| Seed | $8M | Jul 2025 | |
| Series A | $25M | May 2025 | |
| Seed | $6.3M | Apr 2025 | |
| Seed | $5.3M | Apr 2025 | |
| PPhoton Health | Series A | $9M | Aug 2024 |
| Series A | $13.5M | Jul 2024 | |
| Seed | $20M | May 2023 | |
| Seed | $2.8M | Nov 2022 | |
| Series A | $19M | Nov 2022 | |
| Series A | $18.6M | Jul 2022 | |
| Seed | $3M | Jun 2022 | |
| Seed | $4.4M | Jun 2022 | |
| Seed | $5.5M | May 2022 | |
| Series D | $120M | May 2022 | |
| Growth | $200M | Apr 2022 | |
| Series A | $15M | Apr 2022 | |
| Series A | $26M | Mar 2022 | |
| Series A | $20M | Feb 2022 | |
| Series A | $30M | Jan 2022 | |
| Seed | $7.2M | Jan 2022 | |
| Series A | $9M | Oct 2021 | |
| Series A | $20M | Oct 2021 |
Page 1 of 3
Top Co-Investors
First Round Capital9 shared
Founders Fund7 shared
Y Combinator7 shared
SV Angel7 shared
Homebrew5 shared
Index Ventures4 shared
Andreessen Horowitz4 shared
Lux Capital4 shared
Felicis Ventures4 shared
Bloomberg Beta3 shared
BoxGroup3 shared
XYZ Venture Capital3 shared
Slow Ventures3 shared
Fifth Wall3 shared
Long Journey Ventures3 shared
Initialized Capital3 shared
Haystack3 shared
Operator Partners3 shared
Two Sigma Ventures3 shared
Creandum3 shared
Last updated: 8 March 2026